Development Level

Tbio 5 | 10,625

IMPC Phenotype

abnormal behavior 1 | 226
abnormal bone structure 1 | 131
abnormal hair growth 1 | 8
abnormal lens morphology 1 | 73
aorta dilation 1 | 3
decreased bone mineral content 1 | 157
decreased circulating insulin ... 1 | 75
decreased grip strength 1 | 123
increased or absent threshold ... 1 | 128
preweaning lethality, incomple... 1 | 260

Disease

glioblastoma 3 | 5,572
ovarian cancer 3 | 8,491
Breast cancer 2 | 3,098
Intellectual disability 2 | 573
Neurodegenerative disease 2 | 383
Paraplegia 2 | 71
adult high grade glioma 2 | 2,148
atypical teratoid / rhabdoid tumor 2 | 4,369
hereditary spastic paraplegia 2 | 313
medulloblastoma, large-cell 2 | 6,234
osteosarcoma 2 | 7,933
pilocytic astrocytoma 2 | 3,086
primitive neuroectodermal tumor 2 | 3,031
psoriasis 2 | 6,685
Amyotrophic Lateral Sclerosis 1 | 432
Axonal neuropathy 1 | 17
Barth syndrome 1 | 23
Cancer 1 | 2,346
Carcinoma 1 | 2,147
Down syndrome 1 | 548
Lateral sclerosis 1 | 13
Leukemia, Acute Myeloid 1 | 17
Leukemia, Myelocytic, Acute 1 | 113
Peripheral Neuropathy 1 | 303
Pick disease 1 | 1,893
Primary Lateral Sclerosis, Juvenile 1 | 3
Primary lateral sclerosis juvenile 1 | 2
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE (disorder) 1 | 1
Schizophrenia 1 | 503
Sengers syndrome 1 | 17
Sotos syndrome 1 | 15
Spastic Paraplegia, Hereditary 1 | 7
Spastic ataxia 1 | 13
Spastic paraplegia 18, autosomal recessive 1 | 1
Spastic paraplegia 54, autosomal recessive 1 | 1
Waldenstrons macroglobulinemia 1 | 764
Wolf-Hirschhorn syndrome 1 | 32
acute quadriplegic myopathy 1 | 1,157
astrocytic glioma 1 | 2,241
astrocytoma 1 | 1,493
group 3 medulloblastoma 1 | 2,254
group 4 medulloblastoma 1 | 1,875
hereditary spastic paraplegia 18 1 | 1
interstitial cystitis 1 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
juvenile dermatomyositis 1 | 1,189
malignant mesothelioma 1 | 3,163
non-small cell lung cancer 1 | 2,798
oligodendroglioma 1 | 2,849
pancreatic cancer 1 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
posterior fossa group B ependymoma 1 | 1,530
spina bifida 1 | 1,064

Tissue

Blood and immune system 5 | 17,994
Cardiovascular System 5 | 17,957
Digestive Tract 5 | 18,472
Endocrine System 5 | 18,511
Female tissues 5 | 18,646
Liver and Pancreas 5 | 18,135
Male tissues 5 | 17,968
Nervous System 5 | 18,560
Respiratory system 5 | 17,483
Skin and soft tissues 5 | 18,114
Urinary Tract 5 | 18,443

Target Family

Enzyme 2 | 4,146
Non-IDG 2 | 11,969
Epigenetic 1 | 242

Grant Application

2R56CA100724-07A1 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Histone-lysine N-methyltransferase NSD3 NSD3 Tbio Epigenetic -1.29117 15.4 192
Erlin-2 ERLIN2 Tbio Non-IDG -1.24133 18.7 148
Phospholipase DDHD2 DDHD2 Tbio Enzyme -1.21059 15.3 39
U6 snRNA-associated Sm-like protein LSm1 LSM1 Tbio Non-IDG -1.99693 102.2 152
DNA polymerase delta subunit 4 POLD4 Tbio Enzyme -0.84887 7.32 16